Investors can lock in yields of roughly 5% using investment-grade corporate bonds.
The ‘weight-loss trade’ has stalled. What it will take to revive investor interest
The initial euphoria over the GLP-1 drugs like Ozempic has mellowed, but catalysts expected in 2025 could energize investor interest in the stocks.
Health care is looking cheap going into 2025. How to play it with options
Health care stocks have been beset by falling margins, and the new administration may create some uncertainty. How investors can play the sector with options.
These three power stocks have soared on AI demand — the rally might just be starting
The rally in electrical generators is still in a ‘very early phase,’ said Shahriar Pourreza, head of power and utilities at Guggenheim Securities.
Bank of America names Nvidia and these semiconductor stocks top picks for 2025
The firm is standing by Nvidia and some other key semiconductor players in 2025 even after another strong year for the sector.
Wall Street’s least favorite S&P 500 stocks for 2025 have analysts predicting declines
While the stock market has seen record gains this year, several stocks may be due for a pullback.
These are Wall Street’s favorite S&P 500 stocks for 2025 where analysts see 30% upside
These stocks are favored by Wall Street analysts and well positioned for big gains in the year ahead.
Top Wall Street analysts recommend these dividend stocks for higher returns
TipRanks’ analyst ranking service spotlights three dividend-paying stocks, including Walmart and Gaming and Leisure Properties.
The new pro-crypto government could spur a stablecoin boom in 2025. What it means for investors
An upcoming boom in stablecoins and a long-awaited regulatory framework for them could help Coinbase, Robinhood and the U.S. dollar.
AI breakthroughs are speeding up the development of humanoid robots, but investors are still skeptical
Investors seeking AI plays may want to consider humanoid robots, which some analysts expect to begin replacing human workers at scale by the end of the decade.